Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Following adults with obesity at a weight loss clinic as their weight changes

Follows adults with obesity to see which factors relate to weight loss.

Plain-language title generated from the registry record
Registry title: A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change

Key facts

Where
Taipei, TaiwanSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with obesity or overweight who come to a weight loss clinic and are willing to try a weight loss treatment.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Body mass index (BMI) of 27 kg/m² or more, or 24 kg/m² or more with one or more obesity-related health problems.
Earlier treatment
People taking medicines that strongly affect weight (for example long-term steroids or antipsychotics) cannot join if they cannot stop them.

Main reasons for not taking part

  • Pregnant or breastfeeding women
  • Serious mental illness or memory and thinking problems that affect consent or taking part
  • Severe organ failure (for example end-stage kidney disease, cirrhosis, congestive heart failure)
  • Taking medicines that strongly affect weight and cannot stop them
  • Judged unsuitable by the study leader (for example expected to miss follow-up)

Read by machine on 12 November 2026.

Where in Taiwan

  • No.7, Chung Shan S. Rd.(Zhongshan S. Rd.)Taipei, TaiwanNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
National Taiwan University Hospital
Trial code
NCT07239167
Record updated
15 September 2026
Original description
This prospective cohort study collected baseline data and followed up obese patients at their first visit to a weight loss clinic. The study examined the impact of various predictors and biomarkers on weight loss outcomes, aiming to establish an evidence-based foundation for personalized weight loss treatment.Read full original descriptionShow less

A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change

This prospective cohort study collected baseline data and followed up obese patients at their first visit to a weight loss clinic. The study examined the impact of various predictors and biomarkers on weight loss outcomes, aiming to establish an evidence-based foundation for personalized weight loss treatment.

Participants underwent a battery of measurements and questionnaires, including height, weight, waist circumference, blood pressure, blood tests, and questionnaires addressing diet, exercise, stress, sleep, measure handgrip strength ,and psychological well-being.

Inclusion: Adults aged 18 years or older, regardless of gender; Body mass index (BMI) ≥ 27 kg/m², or ≥ 24 kg/m² with one or more obesity-related comorbidities; Willing to undergo any form of weight loss intervention; Able to read and understand Chinese, willing to complete questionnaires, blood tests, and follow-up follow-up; Voluntarily consent to participate and be willing to complete the subject consent form.

Exclusion: Individuals taking medications that significantly affect their weight (e.g., long-term steroids or antipsychotics) and cannot be discontinued; Individuals with significant mental illness (e.g., schizophrenia, severe depression) or cognitive impairment that may affect their ability to consent or cooperate with the study; Individuals with severe organ dysfunction (e.g., end-stage renal disease, cirrhosis, congestive heart failure, etc.); Pregnant or breastfeeding women; Individuals deemed unsuitable for participation in this study by the study leader (e.g., individuals who are expected to be unable to complete follow-up).

ClinicalTrials.gov NCT07239167